Importantly, S3I‐201 down‐regulated the expression of p‐STAT3 and Mcl‐1 in HCC tissues and contributed to the activation of PARP cleavage induced by sorafenib (Figure 7E). This evidence concerns the gene MCL1 and hepatocellular carcinoma.